Zdrowie i gospodarka · 18/06/2018
FDA Announces Draft Guidance for Developing Drugs for Epidermolysis Bullosa
The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for the skin symptoms of epidermolysis bullosa, a rare genetic disorder with limited treatment options.